IO Biotech, Inc.IOBTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+9.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+9.2%/yr
Quarterly compound
Percentile
P82
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 16.47% |
| Q2 2025 | -2.59% |
| Q1 2025 | 16.18% |
| Q4 2024 | -1.66% |
| Q3 2024 | -23.09% |
| Q2 2024 | -6.61% |
| Q1 2024 | 28.34% |
| Q4 2023 | -20.01% |
| Q3 2023 | -7.47% |
| Q2 2023 | -21.91% |
| Q1 2023 | 12.09% |
| Q4 2022 | -28.52% |
| Q3 2022 | 12.64% |
| Q2 2022 | -6.77% |
| Q1 2022 | 20.50% |
| Q4 2021 | -203.82% |
| Q3 2021 | 21.61% |
| Q2 2021 | -135.59% |
| Q1 2021 | -50.18% |
| Q4 2020 | 26.00% |
| Q3 2020 | -64.36% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |